{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:50:01Z","timestamp":1790171401370,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jcrc.2023.154430","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T01:25:14Z","timestamp":1705800314000},"page":"154430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Dose equivalence for metaraminol and noradrenaline \u2013 A retrospective analysis"],"prefix":"10.1016","volume":"80","author":[{"given":"Rahul","family":"Costa-Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ary Serpa","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline Coxwell","family":"Matthewman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Osrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Liskaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daryl","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Udy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Warrillow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcrc.2023.154430_bb0005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/SHK.0000000000001281","article-title":"Incidence, patient characteristics, mode of drug delivery, and outcomes of septic shock patients treated with vasopressors in the arise trial","volume":"52","author":"Udy","year":"2019","journal-title":"Shock."},{"issue":"11","key":"10.1016\/j.jcrc.2023.154430_bb0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.jcrc.2023.154430_bb0015","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.2020.0930","article-title":"Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial","volume":"323","author":"Lamontagne","year":"2020","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.jcrc.2023.154430_bb0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2478\/jccm-2022-0017","article-title":"The use of metaraminol as a vasopressor in critically unwell patients: a narrative review and a survey of UK practice","volume":"8","author":"Grauslyte","year":"2022","journal-title":"J Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcrc.2023.154430_bb0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/1742-6723.13469","article-title":"The Australasian resuscitation in Sepsis evaluation: fluids or vasopressors in emergency department sepsis (ARISE FLUIDS), a multi-centre observational study describing current practice in Australia and New Zealand","volume":"32","author":"Keijzers","year":"2020","journal-title":"Emerg Med Australas"},{"issue":"1","key":"10.1016\/j.jcrc.2023.154430_bb0030","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.bja.2021.09.040","article-title":"Randomised double-blind dose-response study of weight-adjusted infusions of metaraminol for preventing hypotension with combined spinal\u2013epidural anaesthesia for elective caesarean delivery in the supine position","volume":"128","author":"Liu","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jcrc.2023.154430_bb0035","first-page":"547","article-title":"Comparison of effects of metaraminol and norepinephrine on elderly patients with septic shock","author":"Ma","year":"2020","journal-title":"Chin J Emerg Med"},{"issue":"3","key":"10.1016\/j.jcrc.2023.154430_bb0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-59-3-297","article-title":"Studies on the mechanism of action of metaraminol (Aramine)","volume":"59","author":"Harrison","year":"1963","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcrc.2023.154430_bb0045","unstructured":"Metaraminol. MIMS. Retrieved November 1, 2022, from http:\/\/www.mimsonline.com.au\/."},{"issue":"4","key":"10.1016\/j.jcrc.2023.154430_bb0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ejhpharm-2021-003035","article-title":"Comparison of metaraminol versus no metaraminol on time to resolution of shock in critically ill patients","volume":"30","author":"Sardaneh","year":"2023","journal-title":"Eur J Hosp Pharm"},{"issue":"6","key":"10.1016\/j.jcrc.2023.154430_bb0055","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.aucc.2021.01.002","article-title":"Pharmacoepidemiology of metaraminol in critically ill patients with shock in a tertiary care hospital","volume":"34","author":"Sardaneh","year":"2021","journal-title":"Aust Crit Care"},{"key":"10.1016\/j.jcrc.2023.154430_bb0060","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00134-005-2607-3","article-title":"Norepinephrine and metaraminol in septic shock: a comparison of the hemodynamic effects","volume":"31","author":"Natalini","year":"2005","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2023.154430_bb0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/bcp.14969","article-title":"Dose equivalence between metaraminol and norepinephrine in critical care","volume":"88","author":"Sardaneh","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.jcrc.2023.154430_bb0070","first-page":"1","article-title":"The sequential organ failure assessment (SOFA) score: has the time come for an update?","volume":"27","author":"Moreno","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2023.154430_bb0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcrc.2020.11.002","article-title":"Vasopressor dose equivalence: a scoping review and suggested formula","volume":"61","author":"Goradia","year":"2021","journal-title":"J Crit Care"},{"key":"10.1016\/j.jcrc.2023.154430_bb0080","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction\/failure","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.jcrc.2023.154430_bb0085","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1053\/j.jvca.2020.09.117","article-title":"Vasoactive-inotropic score: evolution, clinical utility, and pitfalls","volume":"35","author":"Belletti","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"2","key":"10.1016\/j.jcrc.2023.154430_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-2999(77)90102-9","article-title":"Distribution of metaraminol and its relation to norepinephrine","volume":"44","author":"Anton","year":"1977","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.1016\/j.jcrc.2023.154430_bb0095","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/0024-3205(81)90233-2","article-title":"Tissue levels of metaraminol and its metabolite, \u03b1-methylnorepinephrine, in control and 6-hydroxydopamine-pretreated guinea pigs","volume":"29","author":"Fuller","year":"1981","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.jcrc.2023.154430_bb0100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0006-2952(82)90468-3","article-title":"Mechanisms of accumulation of tyramine, metaraminol, and isoproterenol in isolated chromaffin granules and ghosts","volume":"31","author":"Johnson","year":"1982","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.jcrc.2023.154430_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1476-5381.1968.tb07050.x","article-title":"The formation and release of metaraminol during exposure to warm or cold environments","volume":"34","author":"Johnson","year":"1968","journal-title":"Br J Pharmacol"},{"issue":"12","key":"10.1016\/j.jcrc.2023.154430_bb0110","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/0006-2952(65)90287-X","article-title":"Lack of metaraminol biotransformation by rabbit tissues in vitro","volume":"14","author":"Gram","year":"1965","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.jcrc.2023.154430_bb0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/1440-1681.12694","article-title":"R1 autonomic nervous system in acute kidney injury","volume":"44","author":"Hering","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412300179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412300179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:52:09Z","timestamp":1760125929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088394412300179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":23,"alternative-id":["S088394412300179X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2023.154430","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose equivalence for metaraminol and noradrenaline \u2013 A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2023.154430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154430"}}